This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Reston, VA (US) (2014)
- Heidelberg, DE (2016)
Company Filing History:
Years Active: 2014-2016
Title: Innovations in Cancer Prognosis: The Contributions of Stephanie K Roessler
Introduction
Stephanie K Roessler is a notable inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer research, particularly in the area of predicting patient prognosis for solid tumors. With a total of 2 patents, her work has the potential to impact treatment strategies for patients diagnosed with conditions such as hepatocellular carcinoma and breast cancer.
Latest Patents
Roessler's latest patents focus on a gene signature that predicts the prognosis of patients with solid tumors. This innovative gene signature includes ten tumor-associated genes: SH2D4A, CCDC25, ELP3, DLC1, PROSC, SORBS3, HNRPD, PAQR3, PHF17, and DCK. The research indicates that a decrease in DNA copy number or mRNA expression of certain genes is associated with poor prognosis, while others correlate with a better outcome. The methods described in her patents provide a framework for predicting patient prognosis and offer therapeutic strategies that involve altering the expression or activity of these genes.
Career Highlights
Roessler is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work has garnered attention for its innovative approach to cancer prognosis, showcasing her expertise in molecular biology and genetics.
Collaborations
Roessler collaborates with fellow researcher Xin Wei Wang, contributing to advancements in cancer research and treatment methodologies.
Conclusion
Stephanie K Roessler's contributions to cancer prognosis through her innovative patents highlight the importance of genetic research in improving patient outcomes. Her work exemplifies the intersection of science and technology in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile